Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
With U.S. measles cases hitting a 35-year high at over 3,200 confirmed infections in 2026, eye doctors are now on the front lines of detection. Measles can cause serious ocular complications — from conjunctivitis to corneal scarring and blindness — and ophthalmologists may be the first clinicians to spot it. Falling vaccination rates, now below the 95% herd immunity threshold nationally, are driving the resurgence.
The U.S. is experiencing its worst measles outbreak in 35 years, with over 3,294 confirmed cases across 45 states as of September 2026 — a number not seen since before measles was declared eliminated in 2000. Driven almost entirely by declining vaccination rates (94% of cases are in unvaccinated individuals), the resurgence is putting ophthalmologists in an unexpected but critical role: they may be among the first clinicians to see a measles patient, since conjunctivitis is one of the disease's earliest signs — appearing before the telltale rash.
Measles can cause a spectrum of ocular damage, from mild conjunctivitis to keratitis, corneal ulceration, retinopathy, and optic neuritis. Vitamin A deficiency — even in developed countries, particularly in picky eaters or children with autism — can significantly worsen corneal outcomes. Treatment is largely supportive: lubricants, vitamin A supplementation, and in severe cases, topical steroids. There is no specific antiviral for measles.
Why it matters: Most U.S. ophthalmologists have never seen measles — but that's changing fast. Recognizing the "triple C" triad (cough, coryza, conjunctivitis) and asking about vaccination status could help prevent local outbreaks. Every eye clinic should have a red-eye protocol and isolation room ready.
